400-9696-311 转1
400-9696-311 转3
400-9696-311 转4
400-9696-311 转5
400客服电话
购买数据产品
400-9696-311 转1
定制咨询业务
400-9696-311 转2
数据与AI定制业务
400-9696-311 转3
商务合作及其他问题
400-9696-311 转4
投诉及建议
400-9696-311 转5
ChiCTR2500102879
尚未开始
/
/
/
2025-05-21
/
/
None
Taurine Or Placebo for Healthcare Workers: the TOP Healthcare workers' Bayesian Optimized Phase II randomised-controlled trial
Taurine Or Placebo for Healthcare Workers: the TOP Healthcare workers' Bayesian Optimized Phase II randomised-controlled trial
To assess whether oral taurine supplementation will improve metabolic health of healthcare workers.
随机平行对照
其它
Randomization and data capture will be through the RedCap.
Everyone will be blinded to the study capsules - maybe except the company that manufactures the study capsules in Western Australia. Bottle will be labelled as A or B (with certain serial study number).
Department internal funding
/
40
/
2025-07-01
2027-12-08
/
Healthcare related workers who can read and understand English or Chinese translated version of the study questionnaires will be invited to participate including doctors, nurses, physiotherapists, dietitians, or research-related workers at the New Territories East Cluster Hospitals;
请登录查看(a)Are taking taurine prior to enrolment, (b) Have chronic renal disease (eGFR<30ml/min: as taurine can accumulate in renal failure) (c) Insulin-dependent diabetes mellitus (d) A bleeding disorder (e.g. platelet count < 100x10^9/L or treated with dual antiplatelet agents: as taurine has potential antiplatelet activity in vitro) (e) Received active chemo/immunotherapy < 30 days before enrolment or likely to receive such treatment during the study (f) Pregnant or planning to become pregnant;
请登录查看The Chinese University of Hong Kong
/
德琪医药2026-07-20
动脉网-最新2026-07-20
药精通Bio2026-07-20
求实药社2026-07-20
求实药社2026-07-20
康方生物Akeso2026-07-20
干细胞与外泌体2026-07-20
加科思2026-07-20
良医汇肿瘤资讯2026-07-19
GLP1减重宝典2026-07-19